📰 Solara Active Pharma Sciences News
Page 3 - Solara Active Pharma Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Solara Active Pharma Sciences. Real-time updates on events, politics, business and more.
July 5, 2023
Based on the OI percentage, 55 stocks were on the short-covering list. These included MCX India, IDFC First Bank, Indraprastha Gas, HDFC AMC, and Indiabulls Housing Finance.
June 26, 2023
As many as 88 stocks were on the short-covering list based on the open interest percentage. These included Rain Industries, Hindustan Aeronautics, Dr Lal PathLabs, LIC Housing Finance and Mahanagar Gas
June 26, 2023
63 Moons shares gained nearly 3 percent to close at Rs 207.50 with significantly higher volumes, though there was an erosion of gains from its intraday high of Rs 227.55 due to profit taking.
May 20, 2023
India’s April macro factors have seen improvement with record GST collection, improved PMI numbers, trade deficit narrowing to near two-year lows, and sharp softening in headline and core inflation
May 12, 2023
Stocks to watch: Shares of firms like Tata Motors, HPCL, ONGC, Mankind, Eicher Motors, Cipla, and others will be in focus on Friday's trade.
May 12, 2023
The Board of Directors of Solara Active Pharma Sciences Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2023 - Q4FY23 and FY2023.
February 13, 2023
On the Bombay Stock Exchange (BSE), 1256 stocks advanced, 2337 declined and 166 remained unchanged with advance decline ratio of 0.54, indicating a negative closing of stocks in broader markets.
February 13, 2023
Solara Active Pharma Sciences Ltd announced the successful completion EU-GMP Inspection, carried out jointly by the SUKL, Ministry of Health of the Czech Republic and INFARMED, Portugal at the multi-product manufacturing facility at Cuddalore.
February 4, 2023
According to the findings of a new Future Market Insights (FMI) report, the global Ibuprofen API Market crossed US$ 626.2 Million in 2022 and is expected to grow at a CAGR of 3% to reach US$ 772.2 Million by 2029. The key drivers of the Ibuprofen API market are the ongoing need for low-cost nonsteroidal anti-inflamm...
January 30, 2023
USFDA clears Solara Active's Visakhapatnam facility. The US Food and Drug Administration has cleared Solara Active Pharma Sciences Ltd's new multipurpose active pharmaceutical ingredient manufacturing facility at Visakhapatnam, Andhra Pradesh, with no observation, the company said in an exchange filing.